Theo

Veteran medicinal chemist, program leader, and manager of internal and external FTE’s. 9+ years in the biotechnology industry focused exclusively on small molecule therapeutics. Major contributor to eFFECTOR’s eIF4A inhibitor program, leading to candidate eFT226 (zotatifin, currently in phase 2 clinical trials). Experience leading multidisciplinary teams of scientists to develop cohesive drug discovery strategy and present results to external scientists and investors. Strong track record of success as evidenced by patents, presentations, and publications in peer-reviewed journals.

Willing to travel: 20 miles

Experience: Ph.D. in organic chemistry from UC Irvine and over 5 years of experience as a teaching assistant in organic chemistry. Nearly a decade working in the biotech industry in medicinal chemistry.